2018
DOI: 10.5152/tjg.2018.17570
|View full text |Cite
|
Sign up to set email alerts
|

Diagnosis of cirrhosis in patients with chronic hepatitis C genotype 4: Role of ABCB11 genotype polymorphism and plasma bile acid levels

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 21 publications
(10 citation statements)
references
References 19 publications
0
10
0
Order By: Relevance
“…Stage 3 analysis included replicating SNPs as well as SNPs that have been previously reported to associate with cirrhosis in subpopulations, as described in the introduction (Table ) . As above, we included only SNPs with minor allele count >6 in the European populations of UKBB and MGI, which corresponded to minor allele frequency >0.006.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Stage 3 analysis included replicating SNPs as well as SNPs that have been previously reported to associate with cirrhosis in subpopulations, as described in the introduction (Table ) . As above, we included only SNPs with minor allele count >6 in the European populations of UKBB and MGI, which corresponded to minor allele frequency >0.006.…”
Section: Methodsmentioning
confidence: 99%
“…have been previously reported to associate with cirrhosis in subpopulations, as described in the introduction (Table S1). 5,8,9,[12][13][14][15][16][22][23][24][25][26][27][28][29][30][31][32] As above, we included only SNPs with minor allele count >6 in the European populations of UKBB and MGI, which corresponded to minor allele frequency >0.006. For stage 3 SNPs, a cut-off of P < .05 in either UKBB or MGI was used because there was prior knowledge of their role in liver disease and fibrosis.…”
Section: Stage 3 Analysis Included Replicating Snps As Well As Snps Thatmentioning
confidence: 99%
“…In Egypt, HCC is considered a significant public health problem, where it is responsible for 33.63% and 13.54% of all cancers in males and females corres- The major risk factors for liver cancer in clinical practice are related to hepatitis C viral infection, hepatitis B viral infection, alcoholic and nonalcoholic fatty liver disease [6] [7] [8] [9]. The sequences of chronic HCV infection [10] [11] include the development of liver cirrhosis [12] [13], end stage liver diseases [14] and the progression of HCC depending on different immunological factors and genetic susceptibility [15] Alternative to surgical resection of HCC, Percutaneous thermal ablation is broadly performed as a non-invasive curative treatment for HCC [19].…”
Section: Introductionmentioning
confidence: 99%
“…[1,2] It is the third leading causes of cancer-related death in the world. Chronic infection with hepatitis B virus (HBV) or hepatitis C virus (HCV) has a major role in the development of the disease, therefore, the diagnosis of hepatic fibrosis and inflammation in patients with chronic hepatitis is essential for therapeutic and prognostic implications [36,7] Recently, new markers, including specific gene signatures, have been explored to stratify the risk of recurrence and to improve management of HCC, however, predictive biomarkers are still urgently needed.…”
Section: Introductionmentioning
confidence: 99%